ANI Pharma Inc (18)

Browse by Contract Category

Contracts

Form of Option Agreement (Filed With SEC on March 11, 2021)
Equity Commitment and Investment Agreement dated March 8, 2021 by and between ANI Pharmaceuticals, Inc. and Ampersand 2020 Limited Partnership (Filed With SEC on March 9, 2021)
Support Agreement, dated March 8, 2021 among ANI Pharmaceuticals, Inc., Nile Merger Sub LLC, Novitium Pharma LLC, Esjay Pharma, LLC, Chali Properties, LLC, Chad Gassert, Muthusamy... (Filed With SEC on March 9, 2021)
Transition and Separation Agreement dated February 11, 2021 between ANI Pharmaceuticals, Inc. and Robert Schrepfer (Filed With SEC on February 17, 2021)
Description of Securities (Filed With SEC on March 11, 2021)
Agreement and Plan of Merger dated March 8, 2021 by and among ANI Pharmaceuticals, Inc., Nile Merger Sub LLC, Novitium Pharma LLC, Esjay LLC, Chali Properties, LLC, Chad Gassert,... (Filed With SEC on March 9, 2021)
Inducement Stock Option Award Agreement, effective as of September 8, 2020, between ANI Pharmaceuticals, Inc. and Nikhil Lalwani (Filed With SEC on November 5, 2020)
ANI Pharmaceuticals, Inc. Sixth Amended and Restated 2008 Incentive Plan (Filed With SEC on August 6, 2020)
Employment Agreement between Nikhil Lalwani and ANI Pharmaceuticals, Inc., dated July 24, 2020 (Filed With SEC on August 3, 2020)
Asset Purchase Agreement between Amerigen Pharmaceuticals LTD. and ANI Pharmaceuticals, Inc (Filed With SEC on February 27, 2020)
Form of Non- Statutory Stock Option Agreement (Filed With SEC on February 27, 2020)
Form of Incentive Option Agreement (Filed With SEC on February 27, 2020)
Form of Restricted Stock Grant Agreement (Filed With SEC on February 27, 2020)
Employment Agreement, entered into by the Company and James G. Marken (Filed With SEC on January 22, 2020)
Employment Agreement, entered into by the Company and Robert Schrepfer (Filed With SEC on January 22, 2020)
Employment Agreement, entered into by the Company and Stephen P. Carey (Filed With SEC on January 22, 2020)
Employment Agreement, entered into by the Company and Arthur S. Przybyl (Filed With SEC on January 22, 2020)
Amendment No. 4 to Asset Purchase Agreement between ANI Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc (Filed With SEC on May 9, 2019)